We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $591M invested in Amphastar Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 9
66% more capital invested
Capital invested by funds: $356M → $591M (+$236M)
22% more funds holding
Funds holding: 111 → 135 (+24)
13% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 38
5.22% more ownership
Funds ownership: 51.79% → 57.01% (+5.2%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.36M
Holders
135
Holders Change
+24
Holders Change %
+21.62%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
43
Reduced
38
Closed
9
Calls
–
Puts
$2.36M
Net Calls
-$2.36M
Net Calls Change
-$2.2M
Top Buyers
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$14.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$9.65M |
| 3 |
BlackRock
New York
|
+$7.41M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$4.81M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.45M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$4.16M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$3.11M |
| 3 |
Goldman Sachs
New York
|
-$2.47M |
| 4 |
Morgan Stanley
New York
|
-$2.06M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.83M |
